REFERENCES
SECTION 06 REFERENCES CONTINUED
NHS England - Transformation Directorate: Using a template to support cancer care revie cer-digital-playbook/using-a-template-to-support-cancer-care-reviews/ NHS England: Personalised care and improving quality of life outcomes. Available at https NHS UK Before Surgery https://www.nhs.uk/conditions/having-surgery/preparation/ NHS UK The Eatwell Guide https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food NHS UK MRSA https://www.nhs.uk/conditions/mrsa/
NICE - BNF: Lanreotide https://bnf.nice.org.uk/drugs/lanreotide/ NICE - BNF: Octreotide https://bnf.nice.org.uk/drugs/octreotide/
NICE - Guidance: Avelumab for treating metastatic Merkel cell carcinoma (2018) https://w NICE - Guidance: Avelumab for untreated metastatic Merkel cell carcinoma (2021) https:// NICE - Guidance: Everolimus and sunitinib for treating unresectable or metastatic neuroen guidance/ta449 NICE - Guidance: Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic n Phillips et al (2021) Consensus for the management of pancreatic exocrine insufficiency: U Rinke et al (2009) PROMID Study Group. Placebo-controlled, double-blind, prospective, ra with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Quote: Dale R. Shepard, MD, PhD, Cleveland Clinic, USA. Royal College of Anaesthetists: What does the term “early recovery’ mean? https://www.rc what-does-term Royal College of Anaesthetists: Section 6: Postoperative chest infection https://rcoa.ac.uk
Made with FlippingBook - Share PDF online